102954 Federal Register / Vol. 89, No. 243 / Wednesday, December 18, 2024 / Notices 

molding machines and products 

containing the same’’; 

(3) For the purpose of the 

investigation so instituted, the following 

are hereby named as parties upon which 

this notice of investigation shall be 

served: 

(a) The complainants are: 

Husky Injection Molding Systems LTD., 

500 Queen Street South, Bolton, 

Ontario, Canada L7E 5S5 

Husky Injection Molding Systems, Inc., 

288 North Road, Milton, VT, USA, 

05468 

(b) The respondent is the following 

entity alleged to be in violation of 

section 337, and is the party upon 

which the complaint is to be served: 

NINGBO AO SHENG MOLD CO., LTD., 

d/b/a AOSIMI, No. 8 Xingde Rd. 

Ditang Ave. YuYao, Zhejiang 315480, 

China 

(4) For the investigation so instituted, 

the Chief Administrative Law Judge, 

U.S. International Trade Commission, 

shall designate the presiding 

Administrative Law Judge. 

Responses to the complaint and the 

notice of investigation must be 

submitted by the named respondent in 

accordance with section 210.13 of the 

Commission’s Rules of Practice and 

Procedure, 19 CFR 210.13. Pursuant to 

19 CFR 201.16(e) and 210.13(a), as 

amended in 85 FR 15798 (March 19, 

2020), such responses will be 

considered by the Commission if 

received not later than 20 days after the 

date of service by the complainants of 

the complaint and the notice of 

investigation. Extensions of time for 

submitting responses to the complaint 

and the notice of investigation will not 

be granted unless good cause therefor is 

shown. 

Failure of the respondent to file a 

timely response to each allegation in the 

complaint and in this notice may be 

deemed to constitute a waiver of the 

right to appear and contest the 

allegations of the complaint and this 

notice, and to authorize the 

administrative law judge and the 

Commission, without further notice to 

the respondent, to find the facts to be as 

alleged in the complaint and this notice 

and to enter an initial determination 

and a final determination containing 

such findings, and may result in the 

issuance of an exclusion order or a cease 

and desist order or both directed against 

the respondent. 

By order of the Commission. 

Issued: December 12, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–29906 Filed 12–17–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1444] 

Importer of Controlled Substances 

Application: Leading Pharma LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Leading Pharma LLC to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplementary Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 17, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 17, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on September 27, 2024, 

Leading Pharma LLC, 3 Oak Road, 

Fairfield, New Jersey 07004, applied to 

be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled 

substance Drug code Schedule 

Diphenoxylate ... 9170 II 

The company plans to import the 

listed controlled substance as an 

importer active pharmaceutical 

ingredient for research and development 

toward manufacturing a finished dosage 

product for Food and Drug 

Administration approval. No other 

activity for this drug code is authorized 

for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–29997 Filed 12–17–24; 8:45 am] 

BILLING CODE 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0053] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Leadership 

Engagement Survey (LES) 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Drug Enforcement 

Administration, Department of Justice 

(DOJ), will be submitting the following 

information collection request to the 

Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

January 10, 2025. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 89, No. 243 / Wednesday, December 18, 2024 / Notices 102955 

contact: Tammie Pugh, Section Chief, 

Research and Analysis Staff, Human 

Resources Division, DEA, 

Tammie.S.Pugh@dea.gov, 571–776– 

2496, 600 Army Navy Dr., Arlington, 

VA 22202. 

SUPPLEMENTARY INFORMATION: The 

proposed information collection was 

previously published in the Federal 

Register on 89 FR 81113, October 7, 

2024, allowing a 60-day comment 

period. Written comments and 

suggestions from the public and affected 

agencies concerning the proposed 

collection of information are 

encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number [1117–0053]. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. The Title of the Form/Collection: 

Leadership Engagement Survey. 

3. The agency form number, if any, 

and the applicable component of the 

Department sponsoring the collection: 

N/A. 

4. Affected public who will be asked 

or required to respond, as well as the 

obligation to respond: Federal 

Government/DEA employees, 

contractors, and TFOs working at the 

DEA are encouraged to respond. 

5. Obligation to Respond: The 

obligation to respond is voluntary. 

6. An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The maximum numbers of 

potential respondents is 15000, 

although the expected responses are 

estimated to be 5000. 

7. Estimated Time per Respondent: 

The time per response is 20 minutes to 

complete the Leadership Engagement 

Survey. 

8. Frequency: The LES is 

administered annually. 

9. An estimate of the total annual 

burden (in hours) associated with the 

collection: The total annual burden 

hours for this collection is 

approximately 1650 hours, assuming 

5000 respondents at 20 minutes for each 

response. 

10. An estimate of the total annual 

cost burden associated with the 

collection, if applicable: There is no cost 

to continue the survey since it is already 

fully developed and runs on an internal 

platform accessible only to DEA 

employees. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218, Washington, DC 20530. 

Dated: December 12, 2024. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2024–29752 Filed 12–17–24; 8:45 am] 

BILLING CODE 4410–09–P9 

DEPARTMENT OF JUSTICE 

Notice of Lodging of Proposed 

Consent Decree Under the Toxic 

Substances Control Act 

On December 13, 2024, the 

Department of Justice lodged a proposed 

consent decree with the United States 

District Court for the Southern District 

of New York in the lawsuit entitled 

United States, et al. v. Lilmor 

Management LLC, et al., Civil Action 

No. 24 Civ. 9520. 

In this action, the United States seeks 

injunctive relief pursuant to the Toxic 

Substances Control Act (‘‘TSCA’’) and 

the Residential Lead-Based Paint Hazard 

Reduction Act of 1992 (‘‘RLBPHRA’’) 

against Lilmor Management LLC 

(‘‘Lilmor’’), Morris Lieberman, and 49 

limited liability companies for failure to 

make required disclosures to 

prospective tenants about lead-based 

paint in their apartments as required by 

the Lead Disclosure Rule (24 CFR part 

35, subpart A, and 40 CFR part 745, 

subpart F). As to Lilmor and Lieberman, 

the United States also seeks injunctive 

relief under TSCA for failing to comply 

with safe work practices and related 

requirements during renovations as 

required by the Renovation, Repair, and 

Painting Rule, 40 CFR part 745. The 

United States seeks further relief on a 

theory of public nuisance. The State of 

New York has joined in the suit to assert 

claims under state law. 

The consent decree requires the 

Defendants to pay a $3.25 million 

administrative penalty to the United 

States under TSCA and the RLBPHRA 

and to perform injunctive relief set forth 

in the consent decree, including the 

abatement of lead-based paint and the 

remediation of substandard living 

conditions. In settlement of its claims, 

New York State has agreed to payment 

of $325,000 to a New York City agency 

and creation of a restitution fund of 

$2.925 million. The settlement also 

provides for the hiring of a third-party 

housing expert to oversee settlement 

implementation. 

The publication of this notice opens 

a period for public comment on the 

consent decree. Comments should be 

addressed to the Assistant Attorney 

General, Environment and Natural 

Resources Division, and should refer to 

United States, et al. v. Lilmor 

Management LLC, et al., D.J. Ref. No. 

90–5–1–1–13022. All comments must be 

submitted no later than thirty (30) days 

after the publication date of this notice. 

Comments may be submitted either by 

email or by mail: 

To submit 

comments: Send them to: 

By email ....... pubcomment-ees.enrd@

usdoj.gov. 

By mail ......... Assistant Attorney General, 

U.S. DOJ—ENRD, P.O. 

Box 7611, Washington, DC 

20044–7611. 


khammond on DSK9W7S144PROD with NOTICES